Repligen

Repligen

Life Sciences Tools & Services
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

$9.8B

Market Cap • 10/9/2026

1981

(45 years)

Founded

1986

(40 years ago)

IPO

NASDAQ

Listing Exchange

Flag of United States

United States

Country

Valuation

P/B

4,6

P/S

12,5

P/EBITDA

68,4

P/OCF

72,8

P/FCF

87,6

P/E

238,2

BVPS

37,4

EPS

0,7

Market Cap

Market Cap

9,8B

EV

9,7B

EV/Revenue

12,3

EV/EBITDA

67,6

EV/EBIT

150

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

0,1%

Total Yield

0,1%

Payout

0%

Retained Earnings

469,6M

Profitability

Gross Margin

53,8%

EBITDA Margin

18,3%

EBIT Margin

8,2%

Net Margin

5,3%

D&A/EBITDA

0%

R&D/Revenue

7,2%

Capex/Revenue

2,9%

Capex/D&A

29,1%

Capex/OCF

17%

SBC/OCF

24,7%

% PPE

9,6%

% Goodwill

37,4%

ROE

2%

ROIC

2,5%

Growth

CAGR Revenue 5Y

9,1%

CAGR Op. Income 5Y

-12,1%

CAGR Net Income 5Y

-16,1%

CAGR EPS 5Y

-16,4%

CAGR OCF 5Y

10,1%

Leverage

N.D./EBITDA

—

Debt/Equity

0%

Current Ratio

9,1

Quick Ratio

7,3

Interest Coverage

271,2%

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium